Skip to content

Effect of vagues nerve stimulation on lumbopelvic pain with constipation

Effect of vagues nerve stimulation on lumbopelvic myofascial pain syndrome with chronic functional constipation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20221231056994N1
Enrollment
46
Registered
2023-01-29
Start date
2023-08-23
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: lumbopelvic myofascial pain syndrome. Condition 2: chronic functional constipation. Other chronic pain Constipation

Interventions

Intervention 1: Intervention group: Patients are placed in a room with a temperature of 25±2 degrees in a supine position. In this study, the electroacupuncture is used to stimulate the afferents of a

Sponsors

University of social welfare and rehabilitation sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: Body mass index less than 30 kg/m2 Having at least two signs of the Rome IV criteria The presence of trigger points in at least 3 muscles from the rectus abdominus, psoas major, iliacus, quadratus lumbarum, piriformis, obturator internus, hamstrings, tensor fascia lata, adductors, gluteus medius, gluteus minimus, gluteus maximus and coccygeus on each side using algometer widespread pain index is equal to or greater than 7

Exclusion criteria

Exclusion criteria: Neurological diseases Metabolic and endocrine diseases Thyroid diseases Infectious and inflammatory diseases Myopathy diseases Cardiovascular diseases Systemic diseases such as scleroderma and lupus Cognitive and psychotic diseases Surgeries of the digestive system Long-term use of corticosteroids Addiction and alcohol consumption Taking drugs that affect the autonomic system (such as cholinergic and anticholinergic drugs and alpha and beta blockers) Pregnancy and menopause History of malignancy Hemorrhoid, fissure and grade 3 and 4 rectal prolapse diseases

Design outcomes

Primary

MeasureTime frame
The complete spontaneous bowel movements per week. Timepoint: Before and after 10 sessions of treatment. Method of measurement: The number of times a person has bowel movements per week.

Secondary

MeasureTime frame
Heart rate variability. Timepoint: Before and after 10 sessions of treatment. Method of measurement: PowerLab data acquisition.;Quality of Life scale. Timepoint: Before and after 10 sessions of treatment. Method of measurement: Patient Assessment of Constipation Quality of Life questionnaire.;Beck anxiety level. Timepoint: Before and after 10 sessions of treatment. Method of measurement: Beck Anxiety Inventory.;Pain pressure threshold. Timepoint: Before and after 10 sessions of treatment. Method of measurement: Algometer.;Pain intensity. Timepoint: Before and after 10 sessions of treatment. Method of measurement: Visual Analogue Scale.;Severity constipation. Timepoint: Before and after 10 sessions of treatment. Method of measurement: Wexner questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFariba Khosravi

University of social welfare and rehabilitation sciences

far.khosravi@uswr.ac.ir+98 34 3322 1311

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026